DalCor Pharmaceuticals

DalCor Pharmaceuticals

Biotechnology Research

Montreal, Québec 957 followers

Pioneering Pharmacogenetic Precision Medicine for Cardiovascular Disease

About us

DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development program, dalcetrapib, is intended to reduce fatal and non-fatal myocardial infarction (MI) following a recent acute coronary syndrome and deliver superior cardiovascular outcome in a specific genetic subset of patients.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Montreal, Québec
Type
Privately Held
Founded
2015
Specialties
Precision Medicine, Cardiovascular, and Pharmacogenetics

Locations

  • Primary

    2001 Boulevard Robert-Bourassa

    Montreal, Québec H3A 2A6, CA

    Get directions

Employees at DalCor Pharmaceuticals

Similar pages

Browse jobs

Funding

DalCor Pharmaceuticals 4 total rounds

Last Round

Series D

US$ 80.0M

See more info on crunchbase